Nektar Therapeutics | NKTR - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Agios Pharmaceuticals USD 1.11B 84M 2026-03
ALKERMES USD 1.75B 67.76M 2026-03
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 9.19B 532M 2026-03
Baxter International USD 6.04B 86M 2026-03
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Biogen USD 18.65B 394.9M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cara Therapeutics USD 27.87M 5.06M 2025-09
Cipla INR 329.19B 16.3B 2025-09
Dr.Reddys Laboratories INR 375.76B 13.67B 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Exelixis USD 2.16B 619K 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
Xencor USD 635.59M 10.27M 2025-12